|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
3/2008
vol. 7 abstract:
How to choose a progestogen for hormone therapy of the menopausal period?
Tomasz Pertyński
,
Grzegorz Stachowiak
Przegląd Menopauzalny 2008; 3: 132–137
Online publish date: 2008/07/07
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The choice of a proper progestogen for hormone therapy (HT) of the menopausal period, including its dosage and route of administration, is a crucial element of so-called tailored therapy. Remembering all the indications and contraindications for this kind of treatment one should know that progestogens used in HT are a big group of compounds with different affinity for the receptors – progesterone, estrogen, androgen, mineral- and glucocorticoid – what results in different, in many cases even opposed, final metabolic effects. This knowledge allows to choose the best possible form of progestogen therapy and to avoid, or minimize, some side-effects connecting with this kind of hormone administration.
keywords:
progestogens, hormone therapy, menopause, side-effects, indications, contraindications |